Saving lives through blood-based cancer detection

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation technology. The company develops and commercializes blood-based diagnostic products across multiple cancer indications with high medical need. 

 

tramadol kaufen Deutschland

 

Epigenomics' lead product, Epi proColon®, is a blood-based screening test for the detection of colorectal cancer. Epi proColon® has received marketing approval in the US and is currently marketed in Europe and China.

Epigenomics is an international company with operations in Europe and the United States.